Guardant Health, Inc.
GHNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for GH. That does not mean none is planned.
Get an email about GH's next catalysts
Track Guardant Health (GH) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
How GH's past catalysts played out
Market Overview
Stock performance and key metrics
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers.
WebsiteNo drugs found in this phase.
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
When is Guardant Health, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Guardant Health, Inc. (GH) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track GH biotech catalysts?→
Add GH to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Guardant Health, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.